Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Pang

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
BMC Cancer|July 21, 2019
Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patientsLui Ng, Virginia Kwan, Ariel Chow, et al.
Journal of Gastroenterology and Hepatology|December 17, 2009
Epidemiology of colorectal cancer in AsiaYuk Kei Yee, Victoria P Y Tan, Pierre Chan, et al.
Investigational New Drugs|March 20, 2012
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaThomas Yau, P N Cheng, Pierre Chan, et al.
Gastroenterology|March 27, 2007
Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesisRoberta Pang, Terence K W Lee, Ronnie T P Poon, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 14, 2016
Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinomaAlvin Ho-Kwan Cheung, Colin Siu-Chi Lam, Henry Shiu-Cheung Tam, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Hepatology (Baltimore, Md.)|March 19, 2013
Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasionLui Ng, Ronnie Tung-Ping Poon, Simon Yau, et al.
Journal of Gastroenterology and Hepatology|January 16, 2010
Trend of colorectal cancer in Hong Kong: 1983-2006Yuk Kei Yee, Qing Gu, Ivan Hung, et al.
Journal of Gastroenterology|May 4, 2011
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trialVictoria P Y Tan, Wai M Wong, Ting K Cheung, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
BMC Cancer|July 21, 2019
Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patientsLui Ng, Virginia Kwan, Ariel Chow, et al.
Journal of Gastroenterology and Hepatology|December 17, 2009
Epidemiology of colorectal cancer in AsiaYuk Kei Yee, Victoria P Y Tan, Pierre Chan, et al.
Investigational New Drugs|March 20, 2012
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaThomas Yau, P N Cheng, Pierre Chan, et al.
Gastroenterology|March 27, 2007
Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesisRoberta Pang, Terence K W Lee, Ronnie T P Poon, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 14, 2016
Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinomaAlvin Ho-Kwan Cheung, Colin Siu-Chi Lam, Henry Shiu-Cheung Tam, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Hepatology (Baltimore, Md.)|March 19, 2013
Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasionLui Ng, Ronnie Tung-Ping Poon, Simon Yau, et al.
Journal of Gastroenterology and Hepatology|January 16, 2010
Trend of colorectal cancer in Hong Kong: 1983-2006Yuk Kei Yee, Qing Gu, Ivan Hung, et al.
Journal of Gastroenterology|May 4, 2011
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trialVictoria P Y Tan, Wai M Wong, Ting K Cheung, et al.
Pageof 4